227 related articles for article (PubMed ID: 19593607)
1. Nasal natural killer (NK)/T-cell lymphoma: clinical, histological, virological, and genetic features.
Harabuchi Y; Takahara M; Kishibe K; Moriai S; Nagato T; Ishii H
Int J Clin Oncol; 2009 Jun; 14(3):181-90. PubMed ID: 19593607
[TBL] [Abstract][Full Text] [Related]
2. Monocytes enhance cell proliferation and LMP1 expression of nasal natural killer/T-cell lymphoma cells by cell contact-dependent interaction through membrane-bound IL-15.
Ishii H; Takahara M; Nagato T; Kis LL; Nagy N; Kishibe K; Harabuchi Y; Klein E
Int J Cancer; 2012 Jan; 130(1):48-58. PubMed ID: 21618217
[TBL] [Abstract][Full Text] [Related]
3. Novel treatment for early-stage nasal natural killer/T-cell lymphoma: intra-maxillary arterial infusion chemotherapy with concomitant radiotherapy.
Takahara M; Nagato T; Kishibe K; Ueda S; Komabayashi Y; Yamashina M; Takahashi K; Harabuchi Y
Hematol Oncol; 2017 Jun; 35(2):158-162. PubMed ID: 26563973
[TBL] [Abstract][Full Text] [Related]
4. Immunophenotypic and genotypic characterization of nasal lymphoma with polymorphic reticulosis morphology.
Ohsawa M; Nakatsuka S; Kanno H; Miwa H; Kojya S; Harabuchi Y; Yang WI; Aozasa K
Int J Cancer; 1999 Jun; 81(6):865-70. PubMed ID: 10362131
[TBL] [Abstract][Full Text] [Related]
5. Nasal T/natural killer (NK)-cell lymphomas are derived from Epstein-Barr virus-infected cytotoxic lymphocytes of both NK- and T-cell lineage.
Chiang AK; Chan AC; Srivastava G; Ho FC
Int J Cancer; 1997 Nov; 73(3):332-8. PubMed ID: 9359478
[TBL] [Abstract][Full Text] [Related]
6. Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: Basic Science and Clinical Progress.
Harabuchi Y; Takahara M; Kishibe K; Nagato T; Kumai T
Front Pediatr; 2019; 7():141. PubMed ID: 31041299
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis and management of primary nasal lymphoma of T-cell or NK-cell origin.
Liang R
Clin Lymphoma; 2000 Jun; 1(1):33-7; discussion 38. PubMed ID: 11707809
[TBL] [Abstract][Full Text] [Related]
8. Nasal natural killer/T-cell lymphoma and its association with type "i"/XhoI loss strain Epstein-Barr virus in Chile.
Cabrera ME; Eizuru Y; Itoh T; Koriyama C; Tashiro Y; Ding S; Rey S; Akiba S; Corvalan A
J Clin Pathol; 2007 Jun; 60(6):656-60. PubMed ID: 16775124
[TBL] [Abstract][Full Text] [Related]
9. Characterization of a novel human natural killer-cell line (NK-YS) established from natural killer cell lymphoma/leukemia associated with Epstein-Barr virus infection.
Tsuchiyama J; Yoshino T; Mori M; Kondoh E; Oka T; Akagi T; Hiraki A; Nakayama H; Shibuya A; Ma Y; Kawabata T; Okada S; Harada M
Blood; 1998 Aug; 92(4):1374-83. PubMed ID: 9694726
[TBL] [Abstract][Full Text] [Related]
10. Nasal and nasal-type T/NK-cell lymphoma with cutaneous involvement.
Kato N; Yasukawa K; Onozuka T; Kikuta H
J Am Acad Dermatol; 1999 May; 40(5 Pt 2):850-6. PubMed ID: 10321634
[TBL] [Abstract][Full Text] [Related]
11. P53, N- and K-Ras, and beta-catenin gene mutations and prognostic factors in nasal NK/T-cell lymphoma from Hokkaido, Japan.
Takahara M; Kishibe K; Bandoh N; Nonaka S; Harabuchi Y
Hum Pathol; 2004 Jan; 35(1):86-95. PubMed ID: 14745729
[TBL] [Abstract][Full Text] [Related]
12. Soluble ICAM-1 secretion and its functional role as an autocrine growth factor in nasal NK/T cell lymphoma cells.
Takahara M; Nagato T; Komabayashi Y; Yoshino K; Ueda S; Kishibe K; Harabuchi Y
Exp Hematol; 2013 Aug; 41(8):711-8. PubMed ID: 23583640
[TBL] [Abstract][Full Text] [Related]
13. Nasal T-cell lymphoma: a clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus.
Kanavaros P; Lescs MC; Brière J; Divine M; Galateau F; Joab I; Bosq J; Farcet JP; Reyes F; Gaulard P
Blood; 1993 May; 81(10):2688-95. PubMed ID: 8387835
[TBL] [Abstract][Full Text] [Related]
14. Differences in T-cell-receptor gene rearrangement and transcription in nasal lymphomas of natural killer and T-cell types: implications on cellular origin.
Chiang AK; Srivastava G; Lau PW; Ho FC
Hum Pathol; 1996 Jul; 27(7):701-7. PubMed ID: 8698315
[TBL] [Abstract][Full Text] [Related]
15. Aggressive T/natural killer cell lymphoma presenting as testicular tumor.
Chan JK; Tsang WY; Lau WH; Cheung MM; Ng WF; Yuen WC; Ng CS
Cancer; 1996 Mar; 77(6):1198-205. PubMed ID: 8635144
[TBL] [Abstract][Full Text] [Related]
16. Nasal and nasal-type natural killer (NK)/T-cell lymphoma: immunophenotype and Epstein-Barr virus (EBV) association.
Peh SC; Quen QW
Med J Malaysia; 2003 Jun; 58(2):196-204. PubMed ID: 14569739
[TBL] [Abstract][Full Text] [Related]
17. Expression of cyclin-dependent kinase 6 (cdk6) and frequent loss of CD44 in nasal-nasopharyngeal NK/T-cell lymphomas: comparison with CD56-negative peripheral T-cell lymphomas.
Lien HC; Lin CW; Huang PH; Chang ML; Hsu SM
Lab Invest; 2000 Jun; 80(6):893-900. PubMed ID: 10879740
[TBL] [Abstract][Full Text] [Related]
18. Establishment of an IL-2-dependent cell line derived from 'nasal-type' NK/T-cell lymphoma of CD2+, sCD3-, CD3epsilon+, CD56+ phenotype and associated with the Epstein-Barr virus.
Kagami Y; Nakamura S; Suzuki R; Iida S; Yatabe Y; Okada Y; Kobayashi T; Tsurumi T; Seto M; Ogura M; Taguchi O; Morishima Y
Br J Haematol; 1998 Dec; 103(3):669-77. PubMed ID: 9858215
[TBL] [Abstract][Full Text] [Related]
19. Human interleukin-10 expression in T/natural killer-cell lymphomas: association with anaplastic large cell lymphomas and nasal natural killer-cell lymphomas.
Boulland ML; Meignin V; Leroy-Viard K; Copie-Bergman C; Brière J; Touitou R; Kanavaros P; Gaulard P
Am J Pathol; 1998 Oct; 153(4):1229-37. PubMed ID: 9777954
[TBL] [Abstract][Full Text] [Related]
20. Expression of interleukin-9 in nasal natural killer/T-cell lymphoma cell lines and patients.
Nagato T; Kobayashi H; Kishibe K; Takahara M; Ogino T; Ishii H; Oikawa K; Aoki N; Sato K; Kimura S; Shimizu N; Tateno M; Harabuchi Y
Clin Cancer Res; 2005 Dec; 11(23):8250-7. PubMed ID: 16322282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
